BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-171@pharmaconomics
DTSTAMP:20260707T022204Z
DTSTART;VALUE=DATE:20260529
DTEND;VALUE=DATE:20260530
SUMMARY:MNKD Approval — Afrezza
DESCRIPTION:A final FDA approval decision on Afrezza for type 1 and type 2 diabetes is expected May 29\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/899460/000119312526252544/mnkd-20260529.htm\n\nTrack it: https://www.pharmaconomics.com/e/171
URL:https://www.pharmaconomics.com/e/171
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MNKD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR